2011
DOI: 10.1016/j.jsat.2011.05.002
|View full text |Cite
|
Sign up to set email alerts
|

Changes in methadone maintenance therapy during and after pregnancy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
23
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 28 publications
(23 citation statements)
references
References 24 publications
0
23
0
Order By: Relevance
“…33,34 Furthermore, pharmacodynamic studies show that escalations in dose are needed to maintain the therapeutic effect as pregnancy progresses owing to changes in methadone metabolism. 35 …”
Section: Is Neonatal Abstinence Syndrome a Problem?mentioning
confidence: 99%
“…33,34 Furthermore, pharmacodynamic studies show that escalations in dose are needed to maintain the therapeutic effect as pregnancy progresses owing to changes in methadone metabolism. 35 …”
Section: Is Neonatal Abstinence Syndrome a Problem?mentioning
confidence: 99%
“…The literature search yielded 1 case report 16 and 10 studies [9][10][11][17][18][19][20][21][22][23] discussing the use of methadone in pregnant women. Methadone pharmacokinetics in pregnancy was studied in 3 pharmacokinetic trials, [9][10][11] and split dosing of methadone in pregnant women was described in the case report 16 and in 3 dosing trials.…”
Section: Literature Reviewmentioning
confidence: 99%
“…Methadone pharmacokinetics in pregnancy was studied in 3 pharmacokinetic trials, [9][10][11] and split dosing of methadone in pregnant women was described in the case report 16 and in 3 dosing trials. [17][18][19] Only 4 trials evaluated measurement of methadone concentrations in pregnancy.…”
Section: Literature Reviewmentioning
confidence: 99%
See 1 more Smart Citation
“…Prior observational studies found that women received minimal dose adjustments in the immediate period after delivery (Jones, Johnson et al, 2008; Albright et al, 2011). Postpartum dose reductions to half the third trimester dose as described by CSAT in the quotation above were not described in these studies.…”
Section: Introductionmentioning
confidence: 99%